EVLO News and Press, Evelo Biosciences Inc. From 07/19/23

2023-07-19 17:30:09 ET Gainers: Zions Bancorporation ( ZION ) +8% . Heritage-Crystal Clean ( HCCI ) +7% . CareMax ( CMAX ) +5% . Cabaletta  ( CABA ) +5% . AlloVir ( ALVR ) +4% . Losers: Richardson Electronics ( REL...

2023-07-19 08:30:52 ET Aqua Metals ( AQMS ) -27% after disclosing stock offering . Amarin Corporation ( AMRN ) -20% on plan to undergo restructuring . Biophytis ( BPTS ) -18% on $3.8M offering . Genprex ( GNPX ) -14% on $7.5 Millio...

2023-07-18 13:23:21 ET Gainers: Evelo Biosciences ( EVLO ) +34% . Biophytis S.A. ( BPTS ) +30% . The Singing Machine Company ( MICS ) +29% . Hyperfine ( HYPR ) +31% . Advanced Emissions Solutions ( ADES ) +27% . Innodata ( ...

Evelo Biosciences, Inc. (NASDAQ: EVLO) is one of today's top gainers. The company's shares are currently up 33.48% on the day to $4.74. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developin...

Restructures and reduce s secured debt with Horizon Technology Finance Corporation Appoints two new members and decreases size of Board of Directors CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO) (t...

CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving medicines acting on the small intestinal axis (SINTAX), today announced that it has entered into...

2023-07-05 10:02:39 ET Gainers: Impel Pharmaceuticals ( IMPL ) +32% . Adicet Bio ( ACET ) +18% . C4 Therapeutics ( CCCC ) +17% . NLS Pharmaceutics ( NLSP ) +7% . Poseida Therapeutics ( PSTX ) +4% . Losers: Amneal Pharmaceu...

2023-06-30 08:40:05 ET Renalytix ( RNLX ) +38% jumps 38% after FDA nod for lead product. TOP Financial Group  ( TOP ) +25% . Bright Health Group ( BHG ) +19% enters into definitive agreement with Molina Healthcare to sell its California Medicare Adva...

2023-06-29 09:13:48 ET Evelo Biosciences ( NASDAQ: EVLO ) has announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock. The reverse stock split will become effective at 5:00 p.m. ET today, June 29, 2023, after c...

– EVLO common stock expected to begin trading on a split-adjusted basis on June 30, 2023 – CAMBRIDGE, Mass., June 29, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered i...